The use of terlipressin to treat refractory hypotension during allograft kidney transplantation: a report of 4 cases and literature review
Terlipressin may represent an effective and renal-protective alternative for intraoperative blood pressure maintenance during kidney transplantation. Further controlled studies are warranted to validate the potentials of terlipressin for maintaining perioperative blood pressure and optimizing postoperative allograft function in patients undergoing kidney transplantation.
Authors
- Wen‐He Yang (ORCID: https://orcid.org/0000-0003-3298-0480)
- Xin-Lu Chang
- L.L. Zhang (ORCID: https://orcid.org/0000-0002-6788-5857)
- Yi Cheng
- Fu‐Shan Xue (ORCID: https://orcid.org/0000-0002-1028-6036)
- Yichen Zhu (ORCID: https://orcid.org/0000-0002-8546-1978)
- Lei Wan (ORCID: https://orcid.org/0000-0003-4120-7393)
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Hospital (CN)
- Beijing Municipal Education Commission (CN)
- Beijing Friendship Hospital (CN)
- Fuzhou University (CN)
Publication Details
- Journal
- BMC Anesthesiology
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1186/s12871-025-03443-x
- Primary Topic
- Organ Donation and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00